Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ILT4/CD85d/LILRB2 Antibody (287219R), DyLight 680, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals FAB2078RY

Catalog No. NB366514


Only null left
Add to Cart

Description

Description

ILT4/CD85d/LILRB2 Monoclonal antibody specifically detects ILT4/CD85d/LILRB2 in Human samples. It is validated for Western Blot, Flow Cytometry, Neutralization, CyTOF
Specifications

Specifications

ILT4/CD85d/LILRB2
Monoclonal
DyLight 680
50mM Sodium Borate
Mouse
Protein A or G purified from cell culture supernatant
RUO
Primary
Human
Purified
Western Blot, Flow Cytometry, Neutralization, CyTOF
287219R
Western Blot, Flow Cytometry, Neutralization, CyTOF-ready
CD85 antigen-like family member D, CD85d antigen, Ig-like transcript 4, ILT-4, ILT4CD85d, Immunoglobulin-like transcript 4, Leukocyte immunoglobulin-like receptor 2, leukocyte immunoglobulin-like receptor subfamily B member 2, leukocyte immunoglobulin-like receptor subfamily B member 2 soluble isoform, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR2CD85D, LIR-2subfamily A (with TM domain), member 6, member 2, MIR10LILRA6, Monocyte/macrophage immunoglobulin-like receptor 10
Mouse myeloma cell line NS0-derived recombinant human LILRB2/CD85d/ILT4, Gly24-His458, Accession # ACT64556
0.1 mL
Immunology
10288
Store at 4°C in the dark.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.